Alamab Therapeutics' Unattributed Round

Alamab Therapeutics raised a round of funding on August 04, 2017.

AlaMab Therapeutics, a subsidiary of CSPC Pharmaceutical Group, is developing novel, first-in-class therapies for spinal cord injury and breast cancer bone metastasis.…

Articles about Alamab Therapeutics' Unattributed Round: